System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Dr Somayeh Mojtabavi is an expert in Biochemistry at Tehran University of Medical Sciences (Iran). Somayeh Mojtabavi has authored 122 publications, the most recent in 2026. SLR score: 250 (community average: 125). How the SLR is computed.

LeadR Profile

Dr Somayeh Mojtabavi Tehran University of Medical Sciences Iran
250 ScienceLeadR Reputation 250

Unlock

Register Login
Network Map

Biochemistry

Subspecialties: Endocrinology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2019 - 2026
Source: PubMed

Tehran University of Medical Sciences

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 122

Citations

Citations: 1 384 1st author: 6 Last author: 6 Unique author: 0

Main journals

Sci Rep 30
Bioorg Chem 13
RSC Adv 8
Int J Biol Macromol 7
J Mol Struct 6

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Aniline-linked coumarin-triazole hybrids as α-glucosidase inhibitors: An insightful study from synthesis to in vivo efficacy and mechanistic analysis.
PMID 42925716 — diabetes mellitus, acarbose, biochemistry, triazoles, glucosidases, amides		Bioorg Chem20260
Novel diazene-tri(phenoxy-1,2,3-triazole-acetamide) derivatives as potent α-glucosidase inhibitors: synthesis, biological evaluation, and in silico studies.
PMID 42657213 — diabetes mellitus, acarbose, pharmaceutical preparations, triazoles, glucosidases, enzymes, diabetes mellitus, type 2		RSC Adv20260
Design and synthesis of new donepezil-based chalcones as multi-target-directed ligands against Alzheimer's disease: biological evaluation, molecular dynamics, and zebrafish model studies.
PMID 42453957 — cells, donepezil, chalcones, alzheimer disease, multiple chronic conditions, antioxidants, therapeutics, amyloid, ligands		RSC Adv20260
Novel imidazo[1,2-a]pyridine-based α-glucosidase inhibitors: synthesis, biological evaluations, and computational studies.
PMID 42436199 — glucosidases		Sci Rep20260
Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole-N-phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors.
PMID 42416732 — triazoles, glucosidases		RSC Adv20260

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS